Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.

Over 22 million Americans are diagnosed with ADHD -- yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive(1) Firefly's AI-powered ...

Attention-deficit/hyperactivity disorder or ADHD translates in different ways across the population, unlike the ...

To address this problem, the researchers used a machine-learning approach to divide children with ADHD into subgroups based on their brain structure. This analysis revealed two distinct ADHD subtypes, ...

MRI shows different progressive grey matter volume changes in two ADHD subtypes across symptom severity. Specifically, ADHD subtype 1 exhibits increased GMV, while ADHD subtype 2 shows decreased GMV.

Careful assessment of symptom patterns allows treatment strategies to be aligned with the patient’s specific challenges ...

MRI shows different progressive grey matter volume changes in two ADHD subtypes across symptom severity. Specifically, ADHD subtype 1 exhibits increased GMV, while ADHD subtype 2 shows decreased GMV.

Investing.com -- Firefly Neuroscience Inc (NASDAQ:AIFF) shares jumped 47.7% Friday following the company’s announcement of research advancements using its AI-powered EEG/ERP technology to potentially ...